Financhill
Sell
37

ATRA Quote, Financials, Valuation and Earnings

Last price:
$11.27
Seasonality move :
4.11%
Day range:
$9.86 - $11.47
52-week range:
$6.50 - $39.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.67x
P/B ratio:
--
Volume:
151.8K
Avg. volume:
101.9K
1-year change:
-17.62%
Market cap:
$65.7M
Revenue:
$8.6M
EPS (TTM):
-$25.76
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- -- $20.3M $63.6M $8.6M
Revenue Growth (YoY) -- -- -- 212.55% -86.52%
 
Cost of Revenues -- -- -- -- $8.9M
Gross Profit -- -- -- $63.6M -$313K
Gross Profit Margin -- -- -- -- -3.65%
 
R&D Expenses $216.1M $244.7M $282M $272.5M $224.8M
Selling, General & Admin $79.6M $64.4M $78.8M $71.6M $50.9M
Other Inc / (Exp) -- -- -- $49.5M -$246K
Operating Expenses $295.7M $309.1M $360.8M $344.1M $275.7M
Operating Income -$295.7M -$309.1M -$340.5M -$280.5M -$276M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$291M -$306.6M -$340.1M -$228.3M -$276.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $12K $15K $46K $12K $15K
Net Income to Company -$291M -$306.6M -$340.1M -$228.3M -$276.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$291M -$306.6M -$340.1M -$228.3M -$276.1M
 
Basic EPS (Cont. Ops) -$141.75 -$103.75 -$90.75 -$56.00 -$65.25
Diluted EPS (Cont. Ops) -$141.75 -$103.75 -$90.75 -$56.00 -$65.25
Weighted Average Basic Share $2.1M $3M $3.7M $4.1M $4.2M
Weighted Average Diluted Share $2.1M $3M $3.7M $4.1M $4.2M
 
EBITDA -$288.6M -$300.7M -$331.1M -$222.3M -$266M
EBIT -$295.7M -$309.1M -$340.5M -$227.9M -$270.8M
 
Revenue (Reported) -- -- $20.3M $63.6M $8.6M
Operating Income (Reported) -$295.7M -$309.1M -$340.5M -$280.5M -$276M
Operating Income (Adjusted) -$295.7M -$309.1M -$340.5M -$227.9M -$270.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $5.4M $4.5M $2.1M $40.2M
Revenue Growth (YoY) -- -- -16.97% -52.05% 1779.79%
 
Cost of Revenues -- -- -- $2.6M $7.6M
Gross Profit -- -- $4.5M -$477K $32.6M
Gross Profit Margin -- -- -- -22.31% 81.09%
 
R&D Expenses $59.9M $70.3M $70.2M $56.9M $43.9M
Selling, General & Admin $14.8M $19.8M $18.9M $12.2M $10.4M
Other Inc / (Exp) -- -- -$309K -$27K $555K
Operating Expenses $74.7M $90.2M $89.1M $69.1M $54.3M
Operating Income -$74.7M -$84.8M -$84.6M -$69.6M -$21.8M
 
Net Interest Expenses -- -- -- $177K $724K
EBT. Incl. Unusual Items -$74.3M -$84.7M -$84.1M -$69.8M -$21.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $6K -- $10K -$19K -$17K
Net Income to Company -$74.3M -$84.7M -$84.1M -$69.8M -$21.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$74.3M -$84.7M -$84.1M -$69.8M -$21.9M
 
Basic EPS (Cont. Ops) -$23.00 -$22.50 -$20.50 -$16.40 -$2.93
Diluted EPS (Cont. Ops) -$23.00 -$22.50 -$20.50 -$16.40 -$2.93
Weighted Average Basic Share $3.2M $3.7M $4.1M $4.3M $7.5M
Weighted Average Diluted Share $3.2M $3.7M $4.1M $4.3M $7.5M
 
EBITDA -$72.5M -$82.5M -$82.6M -$67.2M -$19.5M
EBIT -$74.7M -$84.8M -$84M -$68.4M -$20.7M
 
Revenue (Reported) -- $5.4M $4.5M $2.1M $40.2M
Operating Income (Reported) -$74.7M -$84.8M -$84.6M -$69.6M -$21.8M
Operating Income (Adjusted) -$74.7M -$84.8M -$84M -$68.4M -$20.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- $70.9M $4.5M $100.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- $17.4M
Gross Profit -- -- -- -$1.2M $83.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $240.7M $268.4M $289.2M $237.7M $172.4M
Selling, General & Admin $66.3M $73.1M $80.1M $52.7M $41.9M
Other Inc / (Exp) -- -- $49.6M -$303K $605K
Operating Expenses $307.1M $341.5M $369.3M $290.4M $214.3M
Operating Income -$307.1M -$328.8M -$298.4M -$291.6M -$131.2M
 
Net Interest Expenses -- -- -- -- $2.6M
EBT. Incl. Unusual Items -$303.8M -$328.1M -$247M -$290.2M -$133.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $24K $40K $6K $18K
Net Income to Company -$303.8M -$328.1M -$247.1M -$290.2M -$133.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$303.8M -$328.1M -$247.1M -$290.2M -$133.2M
 
Basic EPS (Cont. Ops) -$115.50 -$90.50 -$61.75 -$69.31 -$25.76
Diluted EPS (Cont. Ops) -$115.50 -$90.50 -$61.75 -$69.31 -$25.76
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$299M -$319.7M -$240M -$281.1M -$123.2M
EBIT -$307.1M -$328.8M -$246.9M -$286M -$128.4M
 
Revenue (Reported) -- -- $70.9M $4.5M $100.4M
Operating Income (Reported) -$307.1M -$328.8M -$298.4M -$291.6M -$131.2M
Operating Income (Adjusted) -$307.1M -$328.8M -$246.9M -$286M -$128.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $12.8M $63.4M $4.3M $96.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $5.7M $14.2M
Gross Profit -- -- $63.4M -$1.4M $82M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $179.1M $202.9M $210M $175.2M $122.8M
Selling, General & Admin $48.3M $57M $58.3M $39.5M $30.4M
Other Inc / (Exp) -- -- $49.6M -$234K $617K
Operating Expenses $227.4M $259.9M $268.3M $214.6M $153.2M
Operating Income -$227.4M -$247.1M -$205M -$216M -$71.2M
 
Net Interest Expenses -- $90K -- $177K $2.1M
EBT. Incl. Unusual Items -$225.3M -$246.8M -$153.7M -$215.7M -$72.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $7K $16K $10K $4K $7K
Net Income to Company -$225.3M -$246.8M -$153.7M -$215.7M -$72.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$225.3M -$246.8M -$153.7M -$215.7M -$72.7M
 
Basic EPS (Cont. Ops) -$81.50 -$66.75 -$37.75 -$51.31 -$11.78
Diluted EPS (Cont. Ops) -$81.50 -$66.75 -$37.75 -$51.31 -$11.78
Weighted Average Basic Share $8.4M $11.1M $12.2M $12.6M $19.2M
Weighted Average Diluted Share $8.4M $11.1M $12.2M $12.6M $19.2M
 
EBITDA -$221.2M -$240.2M -$149.1M -$207.9M -$65.2M
EBIT -$227.4M -$247.1M -$153.5M -$211.6M -$69.1M
 
Revenue (Reported) -- $12.8M $63.4M $4.3M $96.2M
Operating Income (Reported) -$227.4M -$247.1M -$205M -$216M -$71.2M
Operating Income (Adjusted) -$227.4M -$247.1M -$153.5M -$211.6M -$69.1M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $74.3M $200.4M $106.1M $92.9M $25.8M
Short Term Investments $184.8M $300.3M $265M $149.9M $25.9M
Accounts Receivable, Net -- $1.3M $986K $40.2M $34.1M
Inventory -- -- -- $1.6M $9.7M
Prepaid Expenses $13.7M $21.2M -- -- --
Other Current Assets -- -- $12.4M $10.3M $6.2M
Total Current Assets $273M $523.3M $384.6M $295.1M $101.9M
 
Property Plant And Equipment $68.2M $62.8M $79.9M $74.3M $58.8M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.8M $2M $3.6M $7M $4.8M
Total Assets $342.9M $588.1M $468.1M $376.4M $165.5M
 
Accounts Payable $8M $7.1M $17.4M $6.9M $3.7M
Accrued Expenses $12.5M $19.9M $19.8M $32.7M $37M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $1.6M $2M $2.8M $13.6M $12.2M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $36.7M $82.9M $105.8M $78.9M $142.2M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $52.2M $125.8M $188.5M $249.8M $264.7M
 
Common Stock $6K $8K $9K $10K $11K
Other Common Equity Adj $220K $296K -$368K -$2.1M -$204K
Common Equity $290.8M $462.3M $279.6M $126.6M -$99.2M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $290.8M $462.3M $279.6M $126.6M -$99.2M
 
Total Liabilities and Equity $342.9M $588.1M $468.1M $376.4M $165.5M
Cash and Short Terms $259.1M $500.7M $371.1M $242.8M $51.7M
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $62.6M $113.2M $65.1M $64.8M $46.5M
Short Term Investments $264.6M $244M $200.3M $37.6M $20.7M
Accounts Receivable, Net -- -- $249K $163K $1.3M
Inventory -- -- -- $6.6M $14M
Prepaid Expenses $12.1M $12.1M $16M -- --
Other Current Assets -- -- -- $9.4M $9.2M
Total Current Assets $339.4M $369.5M $283M $118.7M $91.9M
 
Property Plant And Equipment $64M $78.6M $78.1M $63.8M $47.5M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $2.1M $1.9M $7.2M $6.3M $3.4M
Total Assets $405.5M $449.9M $368.3M $188.8M $142.7M
 
Accounts Payable $5.2M $16.5M $11.3M $6.5M $2.1M
Accrued Expenses $8.9M $10M $17.9M $33.2M $15.1M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- $13.3M $14.7M
Other Current Liabilities $5.3M $9.3M $22.8M -- --
Total Current Liabilities $36.1M $86.2M $72.2M $79.1M $156M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $51.6M $139.8M $181.2M $239.6M $233.2M
 
Common Stock $8K $9K $9K $10K $1K
Other Common Equity Adj $527K $24K -$3M -$571K $22K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- -$14.8M
Minority Interest, Total -- -- -- -- --
Total Equity $353.9M $310.1M $187.1M -$50.8M -$90.5M
 
Total Liabilities and Equity $405.5M $449.9M $368.3M $188.8M $142.7M
Cash and Short Terms $327.2M $357.2M $265.4M $102.4M $67.2M
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$291M -$306.6M -$340.1M -$228.3M -$276.1M
Depreciation & Amoritzation $7.1M $8.3M $9.3M $5.7M $4.8M
Stock-Based Compensation $51.7M $51.4M $53.9M $53.8M $45.4M
Change in Accounts Receivable -- -$1.3M $264K -$39.2M $6.1M
Change in Inventories -- -- -- -$1.6M -$8.1M
Cash From Operations -$235.6M -$180.8M -$220.5M -$270.4M -$193M
 
Capital Expenditures -- -- $10.6M $4.2M $1.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing $60.5M -$120.7M $22.3M $203M $123.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$486K -$389K -$254K -$518K -$947K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$6.7M -$1.7M -$1.3M $29.8M -$107K
Cash From Financing $188.8M $427.6M $103.9M $53.1M $2M
 
Beginning Cash (CF) $62.1M $75.7M $201.8M $107.5M $93.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $13.6M $126.1M -$94.3M -$14.4M -$67.1M
Ending Cash (CF) $75.7M $201.8M $107.5M $93.1M $26M
 
Levered Free Cash Flow -$241.4M -$185.3M -$231.1M -$274.6M -$194.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$74.3M -$84.7M -$84.1M -$69.8M -$21.9M
Depreciation & Amoritzation $2.2M $2.3M $1.4M $1.2M $1.2M
Stock-Based Compensation $13.3M $13.8M $14M $11.1M $6.4M
Change in Accounts Receivable -- -- $388K $344K $1.1M
Change in Inventories -- -- -- $1.3M $4.8M
Cash From Operations -$53M -$59M -$65.1M -$51.3M -$4M
 
Capital Expenditures -- $3.9M $132K $281K --
Cash Acquisitions -- -- -- -- --
Cash From Investing $7.6M $1.2M $59.7M $70.4M -$16.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$92K -$62K -$206K -$208K -$197K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$126K -- -$55K -- --
Cash From Financing $33.5M $47.1M -$214K -$208K $35.8M
 
Beginning Cash (CF) $75.9M $125.3M $72M $46M $31.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$11.9M -$10.6M -$5.6M $18.9M $15.1M
Ending Cash (CF) $64M $114.6M $66.5M $64.9M $46.6M
 
Levered Free Cash Flow -$53.5M -$62.8M -$65.2M -$51.6M -$4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$303.8M -$328.1M -$247.1M -$290.2M -$133.2M
Depreciation & Amoritzation $8.1M $9M $6.9M $4.9M $5.2M
Stock-Based Compensation $51.9M $51.3M $56.5M $46.8M $31.1M
Change in Accounts Receivable -- -- -$249K $86K -$1.2M
Change in Inventories -- -- -- -$6.6M -$7.4M
Cash From Operations -$235.3M -$190.4M -$247.8M -$199.5M -$94.7M
 
Capital Expenditures -- $8.1M $6.6M $1.2M $200K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$82.7M $9.7M $127.4M $165.1M $15.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$430K -$292K -$458K -$854K -$872K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$1.7M -$1.3M -$778K $30.5M -$7K
Cash From Financing $286.2M $231.3M $72.3M $32.8M $61.1M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$31.8M $50.6M -$48.1M -$1.5M -$18.3M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$242M -$199.1M -$254.4M -$200.7M -$94.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$225.3M -$246.8M -$153.7M -$215.7M -$72.7M
Depreciation & Amoritzation $6.2M $6.9M $4.4M $3.6M $4M
Stock-Based Compensation $39.8M $39.8M $42.5M $35.5M $21.2M
Change in Accounts Receivable -- $1.3M $737K $40.1M $32.8M
Change in Inventories -- -- -- -$5M -$4.3M
Cash From Operations -$176.6M -$186.3M -$213.6M -$142.6M -$44.2M
 
Capital Expenditures -- $8.1M $4.2M $1.2M $156K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$83.8M $46.6M $151.7M $113.9M $5.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$289K -$192K -$396K -$732K -$657K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$1.7M -$1.3M -$778K -$107K -$7K
Cash From Financing $248.8M $52.5M $20.8M $498K $59.6M
 
Beginning Cash (CF) $223.2M $479.5M $282.5M $188M $92.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$11.7M -$87.2M -$41M -$28.2M $20.6M
Ending Cash (CF) $211.5M $392.3M $241.5M $159.9M $113.3M
 
Levered Free Cash Flow -$180.6M -$194.4M -$217.7M -$143.8M -$44.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock